Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin for PIB-Associated Chronic Functional Constipation
NCT06571097Recruiting
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levofloxacin in chronic functional constipation (CIC). Primary endpoint: Total effective rate of levofloxacin in the treatment of chronic functional constipation at 6 months. Started Jul 2024; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
chronic functional constipation (CIC)
Beyond the preview
Go deeper on NCT06571097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06571097.